文献速递脊柱脊髓外科

前路可控前移融合术治疗伴椎管狭窄的多节段脊髓型颈椎病:与颈椎前路椎体次全切除融合术的比较

Anterior Controllable Antedisplacement Fusion for Multilevel Cervical Spondylotic Myelopathy with Spinal Stenosis: Comparison with Anterior Cervical Corpectomy and Fusion.
PubMed 文献 · World Neurosurg · 2019-01-17

本研究纳入2016年1月至2017年6月接受前路可控前移融合术(ACAF,36例)或颈椎前路椎体次全切除融合术(ACCF,45例)的多节段脊髓型颈椎病伴椎管狭窄患者,比较两组临床与影像学结果及围手术期并发症。末次随访时两组日本骨科协会评分均较术前显著改善(P<0.01和P<0.01),但两组间差异无统计学意义(13.7±1.9 vs 13.5±1.8,P=0.66)。ACAF组手术时间更长、出血量更多,但并发症总发生率显著低于ACCF组(P<0.05)。

要点

  • ACAF与ACCF术后JOA评分均较术前显著改善(P<0.01和P<0.01)。
  • 两组末次随访JOA评分差异无统计学意义(13.7±1.9 vs 13.5±1.8,P=0.66)。
  • ACAF组手术时间更长、出血量更多,但并发症总发生率显著低于ACCF组(P<0.05)。

核心结论

  • ACAF治疗伴椎管狭窄的多节段脊髓型颈椎病,临床与影像学结果与ACCF相似,且并发症更少。
  • ACAF可作为颈椎椎管狭窄的替代治疗。

研究设计与样本

  • 本研究纳入2016年1月至2017年6月接受ACAF(36例)和ACCF(45例)的多节段脊髓型颈椎病伴椎管狭窄患者。
  • 术前及术后各计划随访时分析日本骨科协会评分以评估神经功能,并分析临床与影像学结果及围手术期并发症。

主要发现

  • 末次随访时,ACAF组和ACCF组平均日本骨科协会评分均较术前显著改善(P<0.01和P<0.01)。
  • 两组平均日本骨科协会评分差异无统计学意义(13.7±1.9 vs 13.5±1.8,P=0.66)。
  • ACAF组手术时间更长、出血量更多。
  • ACAF组并发症总发生率显著低于ACCF组(P<0.05)。

临床怎么用

  • 作者认为ACAF可作为伴椎管狭窄的多节段脊髓型颈椎病的替代治疗。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To introduce anterior controllable antedisplacement fusion (ACAF), a new surgical technique, to treat multilevel cervical spondylotic myelopathy with spinal stenosis and compare ACAF with anterior cervical corpectomy and fusion (ACCF). METHODS: Patients with multilevel cervical spondylotic myelopathy with spinal stenosis who underwent ACAF (36 cases) and ACCF (45 cases) from January 2016 to June 2017 were enrolled in this study. Japanese Orthopaedic Association score was analyzed before the operation and at each scheduled follow-up during the follow-up period after surgery to evaluate neurologic function. Clinical and radiologic outcomes and perioperative complications were analyzed. RESULTS: At the final follow-up, mean Japanese Orthopaedic Association scores of the 2 groups were significantly improved compared with preoperatively (P < 0.01 and P < 0.01). However, mean Japanese Orthopaedic Association scores between the 2 groups were not statistically significant (13.7 ± 1.9 vs. 13.5 ± 1.8, P = 0.66). Operative duration was longer and blood loss was greater in the ACAF group compared with the ACCF group. Overall occurrence of complications in the ACAF group was significantly lower compared with the ACCF group (P < 0.05). CONCLUSIONS: ACAF has similar clinical and radiologic outcomes and fewer complications compared with ACCF in treatment of multilevel cervical spondylotic myelopathy with spinal stenosis. ACAF can be used as an alternative treatment for cervical stenosis.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Wang H, Sun J, Sun K, et al. Anterior Controllable Antedisplacement Fusion for Multilevel Cervical Spondylotic Myelopathy with Spinal Stenosis: Comparison with Anterior Cervical Corpectomy and Fusion. World Neurosurg. 2019. PMID: 30660892. doi:10.1016/j.wneu.2018.12.212

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。